Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements

Because of the low frequency of T cells for any particular soluble protein antigen in unprimed animals, the requirements for naive T cell responses in specific antigens have not been clearly delineated and they have been difficult to study in vitro. We have taken advantage of mice transgenic for the V beta 3/V alpha 11 T cell receptor (TCR), which can recognize a peptide of cytochrome c presented by IEk. 85-90% of CD4+ T cells in these mice express the transgenic TCR, and we show that almost all such V beta 3/V alpha 11 receptor-positive cells have a phenotype characteristic of naive T cells, including expression of high levels of CD45RB, high levels of L-selectin (Mel-14), low levels of CD44 (Pgp-1), and secretion of interleukin 2 (IL-2) as the major cytokine. Naive T cells, separated on the basis of CD45RB high expression, gave vigorous responses (proliferation and IL-2 secretion) to peptide antigen presented in vitro by a mixed antigen-presenting cell population. At least 50% of the T cell population appeared to respond, as assessed by blast transformation, entry into G1, and expression of increased levels of CD44 by 24 h. Significant contributions to the response by contaminating memory CD4+ cells were ruled out by demonstrating that the majority of the CD45RB low, L- selectin low, CD44 high cells did not express the V beta 3/V alpha 11 TCR and responded poorly to antigen. We find that proliferation and IL- 2 secretion of the naive CD4 cells is minimal when resting B cells present peptide antigen, and that both splenic and bone marrow-derived macrophages are weak stimulators. Naive T cells did respond well to high numbers of activated B cells. However, dendritic cells were the most potent stimulators of proliferation and IL-2 secretion at low cell numbers, and were far superior inducers of IL-2 at higher numbers. These studies establish that naive CD4 T cells can respond vigorously to soluble antigen and indicate that maximal stimulation can be achieved by presentation of antigen on dendritic cells. This model should prove very useful in further investigations of activation requirements and functional characteristics of naive helper T cells.

[1]  L. Bradley,et al.  Helper T cell memory: more questions than answers. , 1992, Seminars in immunology.

[2]  M. Croft,et al.  B cell response to T helper cell subsets. II. Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity. , 1991, Journal of immunology.

[3]  M. Croft,et al.  Helper T‐Cell Subsets: Phenotype, Function and the Role of Lymphokines in Regulating their Development , 1991, Immunological reviews.

[4]  L. Bradley,et al.  Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma , 1991, The Journal of experimental medicine.

[5]  P. Linsley,et al.  CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.

[6]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[7]  J. Sprent,et al.  Antigen‐presenting Cells for CD8+ T Cells , 1990, Immunological reviews.

[8]  P. Linsley,et al.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Lee,et al.  Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. , 1990, Journal of immunology.

[10]  M. Jenkins,et al.  Antigen presentation by resting B cells. Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. , 1990, Journal of immunology.

[11]  A. Weinberg,et al.  CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. , 1990, Journal of immunology.

[12]  J. Sprent,et al.  Antigen-presenting cells for Lyt-2+ cells. II. Primary mixed-lymphocyte reactions stimulated by la+ dendritic cells and la −peritoneal exudate cells , 1989 .

[13]  S. Jameson,et al.  Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor , 1989, Nature.

[14]  R. Steinman,et al.  Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction , 1989, The Journal of experimental medicine.

[15]  O. Vainio,et al.  Can B cells turn on virgin T cells? , 1988, Nature.

[16]  R. Steinman,et al.  Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells , 1987, The Journal of experimental medicine.

[17]  H. Macdonald,et al.  Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. , 1987, Journal of immunology.

[18]  R. Steinman,et al.  Accessory cell-T lymphocyte interactions. Antigen-dependent and - independent clustering , 1986, The Journal of experimental medicine.

[19]  R. Steinman,et al.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[21]  M. Crowley,et al.  The surface of dendritic cells in the mouse as studied with monoclonal antibodies. , 1990, International reviews of immunology.

[22]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[23]  R. Fernandez-Botran,et al.  Cellular interactions in the humoral immune response. , 1989, Advances in immunology.